This page is intended for UK patients who have been prescribed remibrutinib for chronic spontaneous urticaria (CSU).1
If you have any questions about your medication, ask your doctor, nurse or pharmacist and read the Patient Information Leaflet (PIL) provided with your medicine.
These resources do not replace the PIL that comes with your medication. The PIL contains additional important information on the use of this medicine that is not fully covered in these resources. Always read the PIL for full information.
Resources
Explore our growing library of resources designed to support you on your treatment journey and to help you better understand CSU.
Guide to CSU and treatment with Rhapsido
Learn more about CSU and your treatment with Rhapsido. This guide explains what CSU is, how Rhapsido works and what to expect during treatment.
Holistic management guide for CSU
Practical advice for living with CSU. This guide has tips that may help you with skin care, sleep, stress and other areas of day-to-day life with CSU.
CSU journal: symptom and medication tracker
Keep track of your CSU symptoms and treatment. This journal can help you see if your symptoms change over time.
Appointment planner for CSU
Get the most out of your CSU appointments. This planner can help you keep track of questions, symptoms and treatment updates to discuss with your healthcare team.
Learn more about CSU
Learn more about remibrutinib
CSU, chronic spontaneous urticaria.
Reference
Rhapsido® (remibrutinib) Patient Information Leaflet.
UK | October 2026 | FA-11763178
Reporting side-effects
If you get side-effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed in the information leaflet that comes in the pack. ▼ The medicine referred to in this material is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side-effects you may get. Please see www.mhra.gov.uk/yellowcard. for instructions on how to report side-effects.
